AdaptHealth ‘nailed it’ with CEO pick, ‘shorts should be nervous,’ says Baird

After AdaptHealth announced that its board of directors has named Crispin Teufel, previously the CEO of Lincare Holdings, as the company’s new CEO, Baird analyst Eric Coldwell said the company “nailed it” with “a slam dunk hire” of an executive with “astute financial skills” and “deep in-industry tenure with CEO and CFO leadership at a strong direct competitor.” The firm, which adds that it “cannot think of a better transition than this” and contends that “shorts should be nervous,” has an Outperform rating and $20 price target on AdaptHealth shares, which are up about 6% to $10 in morning trading.